MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
seen at 10:22, 12 March in News and communications.MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults
seen at 10:22, 12 March in News and communications.